Clal Insurance Enterprises Holdings Ltd Decreases Stock Position in Lam Research Corporation $LRCX

Clal Insurance Enterprises Holdings Ltd cut its holdings in Lam Research Corporation (NASDAQ:LRCX) by 43.3% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 870,000 shares of the semiconductor company’s stock after selling 665,400 shares during the period. Clal Insurance Enterprises Holdings Ltd’s holdings in Lam Research were worth $84,886,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. IMG Wealth Management Inc. bought a new position in shares of Lam Research during the second quarter valued at $26,000. REAP Financial Group LLC purchased a new position in Lam Research in the 2nd quarter worth about $31,000. 1 North Wealth Services LLC bought a new position in Lam Research during the 1st quarter valued at about $36,000. Saudi Central Bank bought a new stake in shares of Lam Research in the first quarter worth approximately $37,000. Finally, Bank of Jackson Hole Trust raised its holdings in shares of Lam Research by 111.1% during the second quarter. Bank of Jackson Hole Trust now owns 380 shares of the semiconductor company’s stock valued at $37,000 after purchasing an additional 200 shares during the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Lam Research Trading Down 2.9%

Shares of LRCX opened at $143.24 on Wednesday. The firm has a market cap of $179.91 billion, a P/E ratio of 31.55, a price-to-earnings-growth ratio of 1.68 and a beta of 1.87. The company has a 50 day simple moving average of $142.35 and a two-hundred day simple moving average of $110.96. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $167.15. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. The company had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s revenue for the quarter was up 27.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be issued a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.7%. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Insider Buying and Selling at Lam Research

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares of the company’s stock, valued at $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Ava Harter sold 9,010 shares of the company’s stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the sale, the insider owned 56,786 shares in the company, valued at $8,942,091.42. This represents a 13.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 102,608 shares of company stock worth $14,916,496. Company insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

LRCX has been the subject of a number of research analyst reports. Rothschild & Co Redburn lifted their target price on shares of Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. UBS Group set a $165.00 price target on Lam Research and gave the stock a “buy” rating in a research note on Thursday, October 23rd. Wells Fargo & Company upped their price objective on Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research report on Thursday, October 23rd. Wall Street Zen downgraded Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, New Street Research boosted their target price on shares of Lam Research from $105.00 to $140.00 and gave the company a “neutral” rating in a research report on Thursday, October 23rd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus price target of $149.04.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.